BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Doeveren T, Nakauma-Gonzalez JA, Mason AS, van Leenders GJLH, Zuiverloon TCM, Zwarthoff EC, Meijssen IC, van der Made AC, van der Heijden AG, Hendricksen K, van Rhijn BWG, Voskuilen CS, van Riet J, Dinjens WNM, Dubbink HJ, van de Werken HJG, Boormans JL. The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder. Int J Cancer 2021;148:981-7. [PMID: 33006377 DOI: 10.1002/ijc.33327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen IA, Chang CH, Huang CP, Wu WJ, Li CC, Chen CH, Huang CY, Lo CW, Yu CC, Tsai CY, Wu WC, Tseng JS, Lin WR, Jiang YH, Lee YK, Jou YC, Cheong IS, Hsueh TY, Chiu AW, Chen YT, Chen JS, Chiang BJ, Tsai YC, Lin WY, Wu CC, Lin JT, Yu CC. Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in Taiwan. Front Oncol 2021;11:766576. [PMID: 35096575 DOI: 10.3389/fonc.2021.766576] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Berndl F, Hassler MR. Molecular intricacies of upper tract urothelial carcinoma and their relevance for therapy considerations. Curr Opin Urol 2022;32:48-53. [PMID: 34772864 DOI: 10.1097/MOU.0000000000000943] [Reference Citation Analysis]
3 Fan B, Huang Y, Wen S, Teng Q, Yang X, Sun M, Chen T, Huang Y, Wang Y, Liu Z. Predictive Value of Preoperative Positive Urine Cytology for Development of Bladder Cancer After Nephroureterectomy in Patients With Upper Urinary Tract Urothelial Carcinoma: A Prognostic Nomogram Based on a Retrospective Multicenter Cohort Study and Systematic Meta-Analysis. Front Oncol 2021;11:731318. [PMID: 34660295 DOI: 10.3389/fonc.2021.731318] [Reference Citation Analysis]
4 Hayashi Y, Fujita K, Netto GJ, Nonomura N. Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma. Front Oncol 2021;11:705440. [PMID: 34395278 DOI: 10.3389/fonc.2021.705440] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Lavoie JM, Vandekerkhove G, Murtha AJ, Wang G, Wyatt AW, Eigl BJ. Development of secondary urothelial carcinoma following complete response to immune checkpoint inhibitors. Urol Case Rep 2021;39:101762. [PMID: 34258232 DOI: 10.1016/j.eucr.2021.101762] [Reference Citation Analysis]
6 van Doeveren T, Nakauma-Gonzalez JA, Mason AS, van Leenders GJLH, Zuiverloon TCM, Zwarthoff EC, Meijssen IC, van der Made AC, van der Heijden AG, Hendricksen K, van Rhijn BWG, Voskuilen CS, van Riet J, Dinjens WNM, Dubbink HJ, van de Werken HJG, Boormans JL. The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder. Int J Cancer 2021;148:981-7. [PMID: 33006377 DOI: 10.1002/ijc.33327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]